Roland Newman - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Roland Newman

Showing results (11-20 of 13) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 13 results.

Journal of the American Board of Family Medicine : JABFM|October 20, 2025

Artificial Intelligence (AI) Adoption, Policies, and Goals in Family Medicine: A Survey of Department ChairsKarl T Clebak, Michael T Partin, Roland Newman, et al.

Cancer Biology & Therapy|March 21, 2020

A novel non-agonist c-Met antibody drug conjugate with superior potency over a c-Met tyrosine kinase inhibitor in c-Met amplified and non-amplified cancersRyo Fujita, Vincent Blot, Eley Wong, et al.

Molecular Oncology|November 19, 2019

TR1801-ADC: a highly potent cMet antibody-drug conjugate with high activity in patient-derived xenograft models of solid tumorsMarco Gymnopoulos, Oscar Betancourt, Vincent Blot, et al.

Pageof 2

Search research articles

Showing results (11-20 of 13) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 13 results.

Journal of the American Board of Family Medicine : JABFM|October 20, 2025

Artificial Intelligence (AI) Adoption, Policies, and Goals in Family Medicine: A Survey of Department ChairsKarl T Clebak, Michael T Partin, Roland Newman, et al.

Cancer Biology & Therapy|March 21, 2020

A novel non-agonist c-Met antibody drug conjugate with superior potency over a c-Met tyrosine kinase inhibitor in c-Met amplified and non-amplified cancersRyo Fujita, Vincent Blot, Eley Wong, et al.

Molecular Oncology|November 19, 2019

TR1801-ADC: a highly potent cMet antibody-drug conjugate with high activity in patient-derived xenograft models of solid tumorsMarco Gymnopoulos, Oscar Betancourt, Vincent Blot, et al.

Pageof 2